Literature DB >> 659729

Comparisons of alum-precipitated and unprecipitated aqueous ragweed pollen extracts in the treatment of hay fever.

P S Norman, L M Lichtenstein.   

Abstract

In 1969 and 1970, groups of patients with ragweed hay fever never before treated were started on preseasonal course of immunization with an alum precipitate of aqueous ragweed extract. A comparison between these two groups of patients and a similar group of patients treated with unprecipitated aqueous extract in 1968 shows that treatment with alum precipitate was safely initiated with fever injections even though a higher dose was administered. The larger cumulative dose appeared to give better IgG antibody responses and greater relief of symptoms. A repeat preseasonal course the next year again required fewer injections of the alum-precipitated extract than a repeat course of aqueous extract.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 659729     DOI: 10.1016/0091-6749(78)90118-5

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  The manufacture of allergenic extracts in North America.

Authors:  P R Hauck; S Williamson
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Desensitisation today.

Authors:  N Eiser
Journal:  BMJ       Date:  1990-06-02

Review 3.  Hyposensitization in asthma: a review.

Authors:  J O Warner
Journal:  J R Soc Med       Date:  1981-01       Impact factor: 5.344

4.  Vaccination with genetically engineered allergens prevents progression of allergic disease.

Authors:  V Niederberger; F Horak; S Vrtala; S Spitzauer; M-T Krauth; P Valent; J Reisinger; M Pelzmann; B Hayek; M Kronqvist; G Gafvelin; H Grönlund; A Purohit; R Suck; H Fiebig; O Cromwell; G Pauli; M van Hage-Hamsten; R Valenta
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

Review 5.  Allergen immunotherapy: past, present and future.

Authors:  Stephen R Durham; Mohamed H Shamji
Journal:  Nat Rev Immunol       Date:  2022-10-17       Impact factor: 108.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.